UCP3 and cancer: As discussed earlier, the upregulation of UCP-2 and UCP-3 was found to contribute to skeletal muscle loss during cancer cachexia, although some studies indicated that the upregulation of UCPs does not have any direct effect on skeletal muscle loss.